SCHEMBL6154720

SCHEMBL6154720

NNC(=S)Nc1cccc(SCc2ccccc2-c2ccccc2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 5/20 0.44
ALDH1A1 P00352 5/20 0.41
GAA P10253 4/20 0.41
MAPT P10636 4/20 0.41
MAPK1 P28482 2/20 0.41
KDM4E B2RXH2 2/20 0.40
RXFP1 Q9HBX9 1/20 0.40
KMT2A Q03164 3/20 0.38
MEN1 O00255 2/20 0.38
ENPP2 Q13822 1/20 0.38
RAB9A P51151 2/20 0.37
NPC1 O15118 1/20 0.37
LMNA P02545 1/20 0.37
ALOX12 P18054 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA9 Q16790 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6154721 0.83 IDO1 (0.46) IDO1ALDH1A1GAAMAPTMAPK1
SCHEMBL6153643 0.75 NPC1 (0.44) ALDH1A1GAAMAPTMAPK1KDM4E
SCHEMBL6243326 0.74 HTT (0.52) IDO1ALDH1A1GAAMAPTKDM4E
SCHEMBL4955280 0.74 DPP4 (0.44) ALDH1A1KMT2ACA12CA1CA2
SCHEMBL6153749 0.73 KMT2A (0.49) IDO1ALDH1A1GAAMAPTKMT2A
SCHEMBL6155072 0.71 ALDH1A1 (0.51) IDO1ALDH1A1GAAKMT2AMEN1
SCHEMBL6153697 0.71 CA12 (0.41) GAAMAPTKMT2ARAB9ANPC1
SCHEMBL5432263 0.70 MAPT (0.69) IDO1ALDH1A1GAAMAPTMAPK1
Isothiocyanate SCHEMBL4959827 0.68 DPP4 (0.43) ALDH1A1MAPTMAPK1KMT2AMEN1
SCHEMBL4959824 0.68 MIF (0.41) ALDH1A1MAPTKMT2AMEN1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050065118-A1 Organosulfur inhibitors of tyrosine phosphatases METABASIS THERAPEUTICS, INC. 2005-03-24 US disclosed
EP-1446110-A2 ORGANOSULFUR INHIBITORS OF TYROSINE PHOSPHATASES Structural Bioinformatics Inc. (US) 2004-08-18 EP disclosed
WO-2003032916-A2 ORGANOSULFUR INHIBITORS OF TYROSINE PHOSPHATASES STRUCTURAL BIOINFORMATICS INC. (US) 2003-04-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050065118-A1 Organosulfur inhibitors of tyrosine phosphatases PTPRS, PTPRJ, PTPRCAP IDO1 1533/4885ALDH1A1 961/4885GAA 2365/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.